James A. Bradac

1.8k total citations
22 papers, 733 citations indexed

About

James A. Bradac is a scholar working on Virology, Epidemiology and Molecular Biology. According to data from OpenAlex, James A. Bradac has authored 22 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 11 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in James A. Bradac's work include HIV Research and Treatment (12 papers), Herpesvirus Infections and Treatments (6 papers) and HIV/AIDS drug development and treatment (5 papers). James A. Bradac is often cited by papers focused on HIV Research and Treatment (12 papers), Herpesvirus Infections and Treatments (6 papers) and HIV/AIDS drug development and treatment (5 papers). James A. Bradac collaborates with scholars based in United States, France and United Kingdom. James A. Bradac's co-authors include Eric Hunter, M. Patricia D’Souza, Daniella Livnat, Sandra H. Bridges, S. Chatterjee, Alan M. Schultz, Bonnie J. Mathieson, Ling Yue, Francine E. McCutchan and Patricia Fast and has published in prestigious journals such as Molecular and Cellular Biology, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

James A. Bradac

22 papers receiving 697 citations

Peers

James A. Bradac

VIROL

EPIDE

IMMUN

D W Lineberger United States

Rukhsana Rahman United States

Hua-Xin Liao United States

Russell D. Schmidt United States

Amapola Manrique Switzerland

Takeo Kuwata Japan

William M. Hurni United States

Livia Pedroza-Martins France

Mary Clare Walker United States

M L Hammarskjöld United States

D W Lineberger United States

James A. Bradac

268 ×0.5

VIROL

245 ×1.0

166 ×0.7

EPIDE

199 ×0.9

IMMUN

224 ×1.4

Citations per year, relative to James A. Bradac James A. Bradac (= 1×) peers D W Lineberger

Countries citing papers authored by James A. Bradac

Since Specialization

Citations

This map shows the geographic impact of James A. Bradac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Bradac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Bradac more than expected).

Fields of papers citing papers by James A. Bradac

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Bradac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Bradac. The network helps show where James A. Bradac may publish in the future.

Co-authorship network of co-authors of James A. Bradac

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Bradac. A scholar is included among the top collaborators of James A. Bradac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Bradac. James A. Bradac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bradac, James A. & Carl W. Dieffenbach. (2009). HIV vaccine development: Lessons from the past, informing the future.. PubMed. 12(7). 435–9. 9 indexed citations

Girard, Marc, Geetha P. Bansal, Livia Pedroza-Martins, et al.. (2008). Mucosal immunity and HIV/AIDS vaccines. Vaccine. 26(32). 3969–3977. 8 indexed citations

Rodriguez‐Chavez, Isaac R., Mary Allen, Edgar L. Hill, et al.. (2006). Current advances and challenges in HIV-1 vaccines. Current HIV/AIDS Reports. 3(1). 39–47. 11 indexed citations

Schultz, Alan M. & James A. Bradac. (2001). The HIV vaccine pipeline, from preclinical to phase III. AIDS. 15. S147–S158. 24 indexed citations

D’Souza, M. Patricia, Daniella Livnat, James A. Bradac, & Sandra H. Bridges. (1997). Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials. The Journal of Infectious Diseases. 175(5). 1056–1062. 130 indexed citations

Mascola, John R., Thomas C. VanCott, James A. Bradac, et al.. (1996). Human Immunodeficiency Virus Type 1 Neutralizing Antibody Serotyping Using Serum Pools and an Infectivity Reduction Assay. AIDS Research and Human Retroviruses. 12(14). 1319–1328. 62 indexed citations

Golding, Hana, M. Patricia D’Souza, James A. Bradac, Bonnie J. Mathieson, & Patricia Fast. (1994). Neutralization of HIV-1. AIDS Research and Human Retroviruses. 10(6). 633–643. 51 indexed citations

Gao, Feng, Ling Yue, Francine E. McCutchan, et al.. (1994). Genetic Variation of HIV Type 1 in Four World Health Organization-Sponsored Vaccine Evaluation Sites: Generation of Functional Envelope (Glycoprotein 160) Clones Representative of Sequence Subtypes A, B, C, and E. AIDS Research and Human Retroviruses. 10(11). 1359–1368. 104 indexed citations

Bradac, James A. & David Ho. (1992). Summary of the Antigenic Variation Working Group. AIDS Research and Human Retroviruses. 8(8). 1419–1421. 1 indexed citations

10.

Bradac, James A., et al.. (1989). Isolation and Characterization of Related cDNA Clones Encoding Skeletal Muscle β-Tropomyosin and a Low-Molecular-Weight Nonmuscle Tropomyosin Isoform. Molecular and Cellular Biology. 9(1). 185–192. 3 indexed citations

11.

Bradac, James A., et al.. (1989). Isolation and characterization of related cDNA clones encoding skeletal muscle beta-tropomyosin and a low-molecular-weight nonmuscle tropomyosin isoform.. Molecular and Cellular Biology. 9(1). 185–192. 15 indexed citations

12.

Bradac, James A. & Eric Hunter. (1986). Polypeptides of Mason-Pfizer monkey virus. III. translational order of proteins on the gag and env gene specified precursor polypeptides. Virology. 150(2). 503–508. 20 indexed citations

13.

Bradac, James A. & Eric Hunter. (1986). Polypeptides of mason-pfizer monkey virus II. Synthesis and processing of the env gene products. Virology. 150(2). 491–502. 12 indexed citations

14.

Chatterjee, S., James A. Bradac, & Eric Hunter. (1985). A rapid screening procedure for the isolation of nonconditional replication mutants of Mason-Pfizer monkey virus: Identification of a mutant defective in pol. Virology. 141(1). 65–76. 15 indexed citations

15.

Barker, Christopher S., John W. Wills, James A. Bradac, & Eric Hunter. (1985). Molecular cloning of the Mason-Pfizer monkey virus genome: Characterization and cloning of subgenomic fragments. Virology. 142(2). 223–240. 19 indexed citations

16.

Bradac, James A. & Eric Hunter. (1984). Polypeptides of Mason-Pfizer monkey virus I. Synthesis and processing of the gag-gene products. Virology. 138(2). 260–275. 66 indexed citations

17.

Chatterjee, S., James A. Bradac, & Eric Hunter. (1982). Effect of monensin on Mason-Pfizer monkey virus glycoprotein synthesis. Journal of Virology. 44(3). 1003–1012. 30 indexed citations

18.

Chatterjee, S., James A. Bradac, & Eric Hunter. (1981). Effect of tunicamycin on cell fusion induced by Mason-Pfizer monkey virus. Journal of Virology. 38(2). 770–776. 22 indexed citations

19.

Bradac, James A., et al.. (1979). Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary disease. Antimicrobial Agents and Chemotherapy. 16(3). 353–361. 32 indexed citations

20.

Sloyer, John L., et al.. (1977). Immune response to acute otitis media in children III. Implications of viral antibody in middle ear fluid.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 118(1). 248–50. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact